Cordis Corporation Launches New Peripheral Angioplasty Balloon Catheters

Main Category: Cardiovascular / Cardiology
Also Included In: Medical Devices
Article Date: 07 May 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Cordis Corporation (NYSE:JNJ) announced the U.S. launch of the SLEEK™ and SAVVY® Long PTA Balloon Dilatation Catheters, its most advanced percutaneous transluminal angioplasty (PTA) balloon catheters.

Todd M. Pope, Worldwide President, Cordis Corporation said, "These products incorporate our most advanced balloon technology and underscore our commitment to providing physicians with a full range of treatment options for patients with peripheral vascular disease."

The SLEEKTM Balloon is one of the first .014" guidewire compatible rapid-exchange (Rx) balloons fully dedicated to infrapopliteal vessels, while the SAVVY® Long Balloon provides an .018" guidewire compatible over-the-wire (OTW) alternative for both superficial femoral and infrapopliteal arteries. With balloon lengths up to 220mm, the longest available for superficial femoral and infrapopliteal use, the SLEEKTM and SAVVY® Long Balloons may enable physicians to treat long, diffuse lesions with fewer inflations and faster procedures compared to traditional PTA balloons.

About Cordis Corporation

Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in developing and manufacturing interventional vascular and gastroenterology technology. Through research, development and innovation, physicians worldwide are better able to treat the millions of patients who require interventional procedures.

Cordis Corporation